Statement Of Comprehensive Income [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183076

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	—	59 620 EUR	59 620 EUR	—	—	—	—	116 875 EUR	116 875 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, before tax [abstract]
Other comprehensive income, before tax, gains (losses) from investments in equity instruments	—	—	10 461 EUR	—	—	—	—	—	6 508 EUR	—
Components of other comprehensive income that will be reclassified to profit or loss, before tax [abstract]
Cash flow hedges [abstract]
Other comprehensive income, before tax, cash flow hedges	—	—	10 449 EUR	—	—	—	—	—	14 390 EUR	—
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss [abstract]
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss	—	—	2 612 EUR	—	—	—	—	—	3 597 EUR	—
Other comprehensive income	—	—	18 298 EUR	—	—	—	—	—	17 300 EUR	—
Comprehensive income	- EUR	18 298 EUR	77 918 EUR	59 620 EUR	- EUR	17 300 EUR	- EUR	- EUR	134 175 EUR	116 875 EUR
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	—	77 918 EUR	—	—	—	—	—	134 175 EUR	—
Comprehensive income, attributable to non-controlling interests	—	—	- EUR	—	—	—	—	—	- EUR	—